|
595 Pharmacists
should not worry about starting ETP Pharmacists should not
be concerned if they feel that they do not yet know what is happening
with electronic transfer of prescriptions, according to Tim Donohoe,
group programme director for the National Programme for IT ...more
595 Scotland
committed to community pharmacy Scotland's new health plan
is evidence of the Scottish Executive's commitment to community pharmacy,
according to Frank Owens, chairman of the Scottish Pharmaceutical General
Council ...more
595 Prescription Pricing Authority aims to save £20m a year Costs of processing prescription payments are likely to be reduced by £20m, following the introduction of a new IT system according to the Prescription Pricing Authority
...more
595 Scottish
health boards told to prepare for new contract How NHS boards
in Scotland need to prepare for the implementation of the electronic
minor ailments service (eMAS) was set out by the Scottish Executive this
week ...more
596 Early clopidogrel
prevents deaths Early clopidogrel (Plavix) therapy could prevent
5,000 deaths if given to one million of the 10 million patients who have
a heart attack each year, researchers argue in The Lancet last week ...more
596 Minister
launches Boots chlamydia service Boots The Chemists begins
a government-funded chlamydia screening service on 14 November ...more
596 Confidentiality
for under 16s challenged in High Court This week, a mother challenged Department of Health guidelines on confidentiality at a judicial review in the High Court. The DoH guidelines state that girls under 16 years can receive advice on contraception and have a termination without their parents' knowledge
...more
596 Give beta-blockers
after MI patients have stabilised Use of early beta-blocker
therapy in acute myocardial infarction reduces the risks of reinfarction
and ventricular fibrillation, but increases the risk of cardiogenic shock,
especially during the first day or so after admission to hospital, researchers
have found ...more
596 5mg Crestor
dose for Asians Asian patients and patients with predisposing
factors for myopathy should start rosuvastatin (Crestor) treatment on
a 5mg dose, AstraZeneca announced last week ...more
596 Superdrug
recruits Superdrug has announced a recruitment drive for its
225 pharmacies ...more
597 Patients
could register with pharmacist and GP Community pharmacists
could be the point of registration for patients and employ a GP to provide
medical services from their premises, according to the NHS Confederation
...more
597 Drug errors
make up 7.1pc of safety incidents Medication errors are the
second biggest cause of known patient safety incidents in the NHS, according
to a report published last week by the National Audit Office ...more
597 Controlled
Drug handwriting requirements end next week Doctors will no
longer have to hand-write prescriptions for Controlled Drugs from 14
November ...more
598 Use extended
roles for diabetes care for children Community pharmacists
could use their extended roles to help fill a gap in services for children
with diabetes, it was suggested last week, ahead of World Diabetes Day
on 14 November ...more
598 Tackling
diabetes epidemic involves everyone All sections of society
need to engage with the global type 2 diabetes epidemic if a catastrophe
is to be prevented, David Matthews, chairman of the Oxford Centre for
Diabetes, Endocrinology and Metabolism, said at an Oxford Health Alliance
forum in London this week ...more
598 Pharmacists'
invention wins innovation prize An eye-drop bottle holder based on an idea from two pharmacists has won the Johnson & Johnson Award for Best Medical Device Innovation at the Medical Futures Innovations awards held in London last week
...more
598 Pharmacists
are likely to be out of pocket under DoH patient pack proposals Community
pharmacists could be out of pocket if Government proposals to encourage
patient pack dispensing go ahead, the Company Chemists Association has
warned ...more
599 Pharmacies
could save the NHS millions a day GP consultations about minor ailments, which could be better treated with advice from a pharmacist together with over-the-counter medicines, cost the NHS £7.5m a day, according to a new consumer survey
...more
599 Multidisciplinary
care influences concordance Patients who are cared for by
multidisciplinary teams are beginning to receive mixed messages about
their medicines, according to research into patient choice and medicine-taking
commissioned by the Pharmacy Practice Research Trust as part of its Medicines
and People Programme ...more
599 Pharmacists
advised to label oxygen cylinders Community pharmacies in England and Wales have been told to label all oxygen cylinders they supply to patients from now on with the pharmacy name, address and telephone number. This is so pharmacists can be told when to recover the cylinders once the new regionally contracted oxygen suppliers have taken the patients on
...more
599 Waste could
be cut if people ask about their medicines Millions of pounds could be saved each year if the public asked more questions about their medicines, according to Joanne Shaw, director of Ask About Medicines Week, which took place from 7–11 November
...more
|
600 SMC recommends
six medicines and rejects three Guidance published this week
by the Scottish Medicines Consortium accepts six medicines for use within
NHS Scotland and rejects three ...more
600 Rapid NICE
assessments planned for single indication drugs New drugs
with a single indication, plus new indications for licensed drugs, will
be put through a more rapid assessment process, the National Institute
for Health and Clinical Excellence announced last week ...more
600 Inform patients
about unfunded medicines It is unethical to withhold information
about treatments from patients because of concerns about their capacity
to pay, even if such discussions cause distress to some patients, a group
of Australian oncologists argue ...more
600 Appointments
to the CHM announced Two pharmacists — Tony Nunn and
Roger Walker — have been appointed to the Commission on Human Medicines,
which superseded the Committee on Safety of Medicines and the Medicines
Commission on 1 November ...more
601 Capecitabine
improves survival in pancreatic cancer Adding the oral chemotherapy
drug capecitabine (Xeloda) to standard chemotherapy with gemcitabine
(Gemzar) increases survival for patients with advanced pancreatic cancer,
results from one of the largest trials in this type of cancer have shown
...more
601 Available
evidence on Herceptin is insufficient Available evidence on
trastuzumab (Herceptin) is insufficient to make firm judgements on its
efficacy and safety, an editorial in this week's issue of The Lancet argues
...more
601 Ibandronate
better tolerated than zoledronic acid Treatment with the oral
bisphosphonate ibandronate achieved similar efficacy but was better tolerated
than intravenous zoledronic acid in treating metatastic bone disease,
a study presented at ECCO has shown ...more
601 Bicalutamide
reduces risk of death in prostate cancer Treating men with
locally advanced prostate cancer with bicalutamide (Casodex) plus radiotherapy
reduces the risk of death by more than one-third compared with radiotherapy
alone, according to new results from the Early Prostate Cancer Trial
...more
R&D news
602 Safety concerns
raised over new diabetes drug Safety concerns over a new drug
to treat type 2 diabetes have been raised in a paper published online
...more
602 Benefit of
gefitinib limited to patient subgroup Benefits of gefitinib
(Iressa) as a second-line treatment for patients with non-small-cell
lung cancer are limited to those of Asian origin and those who have never
smoked, a post-marketing study published last month suggests ...more
602 Positive
results from HPV vaccine trials continue Encouraging results
continue to emerge from trials of vaccines that target the human papillomavirus
(HPV) types associated with 70 per cent of cervical cancers and 90 per
cent of genital warts ...more
602 New antifungal
agent data Posaconazole (Noxafil), a new triazole antifungal
agent, has demonstrated superior efficacy to fluconazole in preventing
aspergillosis in allogeneic haematopoietic stem cell transplant recipients
with graft versus host disease ...more
602 Post-operative
vomiting Post-operative vomiting is more effectively reduced
by a new class of drugs, called NK-1 receptor antagonists, than by ondansetron,
according to a phase III trial presented at the American Society of Anesthesiologists
meeting in Atlanta last month ...more
|
The
Pharmaceutical Journal